| 
 | Compound Information | SONAR Target prediction |  | Name: | Rimexolone |  | Unique Identifier: | Prest1297 |  | MolClass: | Checkout models in ver1.5 and ver1.0 |  | Molecular Formula: | C24H34O3 |  | Molecular Weight: | 339.279 g/mol |  | X log p: | 4.786  (online calculus) |  | Lipinksi Failures | 0 |  | TPSA | 34.14 |  | Hydrogen Bond Donor Count: | 0 |  | Hydrogen Bond Acceptors Count: | 3 |  | Rotatable Bond Count: | 2 |  | Canonical Smiles: | CCC(=O)C1(C)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C |  | Generic_name: | Rimexolone |  | Chemical_iupac_name: | 11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cy clopenta[a]phenanthren-3-one
 |  | Drug_type: | Approved Drug |  | Pharmgkb_id: | PA451254 |  | Drugbank_id: | APRD01220 |  | H2o_solubility: | Insoluble |  | Logp: | 4.498 |  | Cas_registry_number: | 49697-38-3 |  | Drug_category: | Anti-inflammatory agents; Corticosteroids; ATC:H02AB12; ATC:S01BA13 |  | Indication: | For the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior uveitis.
 |  | Pharmacology: | Rimexolone is a glucocorticoid corticosteroid for systemic use. Corticosteroids suppress the inflammatory response to a variety of inciting agents of a mechanical,
 chemical, or immunological nature. They inhibit edema, cellular infiltration,
 capillary dilatation, fibroblastic proliferation, deposition of collagen and scar
 formation associated with inflammation.
 |  | Mechanism_of_action: | Betamethasone is a glucocorticoid receptor agonist. The antiinflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory
 proteins which, through inhibition of arachidonic acid, control the biosynthesis of
 prostaglandins and leukotrienes.
 |  | Organisms_affected: | Humans and other mammals | 
 
 
	
		| Species: | 9606 |  
		| Condition: | TMPPre002 |  
		| Replicates: | 2 |  
		| Raw OD Value: r im | 5802.5000±0 |  
		| Normalized OD Score: sc h | 0.9165±0 |  
		| Z-Score: | -1.8812±0 |  
		| p-Value: | 0.0599464 |  
		| Z-Factor: | -7.92757 |  
		| Fitness Defect: | 2.8143 |  
		| Bioactivity Statement: | Nonactive |  | | Experimental Conditions |  |  | Library: | Prestwick |  | Plate Number and Position: | 13|F11 |  | Drug Concentration: | 50.00 nM |  | OD Absorbance: | 0 nm |  | Robot Temperature: | 23.50 Celcius |  | Date: | 2006-10-10 YYYY-MM-DD |  | Plate CH Control (+): | 727.5±605.08760 |  | Plate DMSO Control (-): | 773±261.27974 |  | Plate Z-Factor: | -83.4256 | 
 |  png ps
 pdf
 | 
 
 
	
		| 6604405 | (8S,9S,11R,13R,14R,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahyd ro-6H-cyclopenta[a]phenanthren-3-one
 |  
 | internal high similarity DBLink  | Rows returned: 0 |  | 
 
 | active | Cluster 17014 | Additional Members: 17 | Rows returned: 2 |  | 
 
 |